BurstDR
Device
Abbott Laboratories
Total Payments
$215,737
Transactions
147
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $8,500 | 2 | 0 |
| 2019 | $207,237 | 145 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $215,737 | 147 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG) | Abbott Laboratories | $161,212 | 2 |
| EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial (DELIVERY) | Abbott Laboratories | $43,107 | 0 |
| Success Using Neuromodulation with BURST (SUNBURST) Study | Abbott Laboratories | $2,918 | 0 |
| CHANGE-LBP Study | Abbott Laboratories | $1,000 | 0 |
Ad
Manufacturing Companies
- Abbott Laboratories $215,737
Product Information
- Type Device
- Total Payments $215,737
- Total Doctors 2
- Transactions 147
About BurstDR
BurstDR is a device associated with $215,737 in payments to 2 healthcare providers, recorded across 147 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2020. In 2020, $8,500 was paid across 2 transactions to 0 doctors.
The most common payment nature for BurstDR is "Unspecified" ($215,737, 100.0% of total).
BurstDR is associated with 4 research studies, including "PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG)" ($161,212).